LI
TEVA icon

LRI Investments’s Teva Pharmaceuticals TEVA Stock Holding History

LRI Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
3,143
+1,118
+55% +$37.2K 0.01% 439
2026
Q1 		$61K Hold
2,025
– – 0.01% 484
2025
Q4 		$63.2K Sell
2,025
-788
-28% -$19.4K 0.01% 504
2025
Q3 		$56.8K Buy
2,813
+2,000
+246% +$35.1K ﹤0.01% 532
2025
Q2 		$13.6K Hold
813
– – ﹤0.01% 780
2025
Q1 		$12.5K Hold
813
– – ﹤0.01% 750
2024
Q4 		$17.9K Hold
813
– – ﹤0.01% 688
2024
Q3 		$13.6K Hold
813
– – ﹤0.01% 719
2024
Q2 		$13.2K Hold
813
– – ﹤0.01% 692
2024
Q1 		$11.5K Buy
+813
New +$10.2K ﹤0.01% 478

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

LRI Investments's TEVA Position: Q2 2026 in Review

LRI Investments increased its Teva Pharmaceuticals (TEVA) stake by 55% in Q2 2026, buying an estimated $37.2K and bringing the position to 3,143 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #439.

LRI Investments first reported a position in TEVA in Q1 2024 and has held it in 10 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • LRI Investments held 3,143 shares of Teva Pharmaceuticals worth $106K as of Q2 2026.
  • LRI Investments bought 1,118 Teva Pharmaceuticals shares in Q2 2026, an estimated $37.2K.
  • Teva Pharmaceuticals made up 0.01% of LRI Investments's portfolio in Q2 2026, its #439 holding.
  • LRI Investments first reported a position in Teva Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.